跳至主要内容
临床试验/NL-OMON35827
NL-OMON35827已完成2 期

ADDED VALUE OF 18FDG-PET-CT IN THE DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS - Value of FDG-PET-CT in fungal infections in neutropenic patients

niversitair Medisch Centrum Groningen0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Adult patients (age > 18 years) with a hematologic disease who probably or possibly have an IFI. That means:
  • * Prolonged (or expected prolonged) neutropenia (leukocyte count < 1,0x109 or granulocyte count < 0,5x109, or leukocyte count < 1,5x109 or granulocyte count < 1,0x109 and decreasing due to chemotherapy), and
  • * Axillary temperature * 38, 5°C, not reacting on treatment with wide-spectrum antibacterial drugs for 72 hours, and
  • * A positive HR-CT scan, suspect for an IFI and
  • o A positive galactomannan-test in serum or fluid acquired by BAL, or positive in both materials (N<=6)
  • o A negative galactomannan-test GM in both serum and BAL fluid (N<=6)

排除标准

  • * Patients with age < 18 years
  • * Female patients who are pregnant
  • * Patients with claustrophobia or other reasons that make the scanning impossible, such as unable to lie still, need of oxygen, and so on.
  • * Patients who are hemodynamically instable
  • * (Pre)terminal patients for which the investigation is too burdensome
  • * Patients who may clinically not be able to undergo the study
  • * Patients without prolonged or expected prolonged immunocompromised condition (less than 14 days)
  • * Patients without positive signs of IFI on HR-CT

研究者

相似试验